Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 209,426 | -192,446 | -13,109 | -10,408 | 38,997 |
| Depreciation Amortization | 36,071 | 63,101 | 36,419 | 15,720 | 68,637 |
| Income taxes - deferred | 121 | -94,703 | -21,294 | -12,078 | -29,558 |
| Accounts receivable | -122,175 | 36,818 | 38,954 | 61,960 | -121,110 |
| Other Working Capital | -152,152 | -47,663 | -50,196 | 25,045 | -19,069 |
| Other Operating Activity | 143,769 | 338,950 | 37,812 | -1,334 | 154,555 |
| Operating Cash Flow | $115,060 | $104,057 | $28,586 | $78,905 | $92,452 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 195,314 |
| PPE Investments | -122,756 | -30,514 | -19,166 | -10,882 | -25,199 |
| Net Acquisitions | N/A | -585,800 | N/A | N/A | -691,348 |
| Purchase Sale Intangibles | -1,850 | 0 | N/A | -3,500 | 59,546 |
| Other Investing Activity | -1,850 | 11,500 | 11,500 | -3,500 | 53,696 |
| Investing Cash Flow | $-124,606 | $-604,814 | $-7,666 | $-14,382 | $-467,537 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 225,000 | 400,000 | N/A | N/A | 1,035,000 |
| Debt Repayment | -11,396 | 0 | N/A | N/A | -435,000 |
| Common Stock Issued | N/A | 9,137 | 9,178 | 7,662 | 99,792 |
| Other Financing Activity | -233,099 | -17,649 | -4,263 | -1,003 | -198,931 |
| Financing Cash Flow | $-19,495 | $391,488 | $4,915 | $6,659 | $500,861 |
| Exchange Rate Effect | 1,481 | 1,041 | 660 | 645 | -298 |
| Beginning Cash Position | 65,106 | 340,351 | 340,351 | 340,351 | 214,873 |
| End Cash Position | 37,546 | 232,123 | 366,846 | 412,178 | 340,351 |
| Net Cash Flow | $-27,560 | $-108,228 | $26,495 | $71,827 | $125,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | 115,060 | 104,057 | 28,586 | 78,905 | 92,452 |
| Capital Expenditure | -122,756 | -31,860 | -20,512 | -10,882 | -25,199 |
| Free Cash Flow | -7,696 | 72,197 | 8,074 | 68,023 | 67,253 |